BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 21700708)

  • 1. Inducible nitric-oxide synthase and nitric oxide donor decrease insulin receptor substrate-2 protein expression by promoting proteasome-dependent degradation in pancreatic beta-cells: involvement of glycogen synthase kinase-3beta.
    Tanioka T; Tamura Y; Fukaya M; Shinozaki S; Mao J; Kim M; Shimizu N; Kitamura T; Kaneki M
    J Biol Chem; 2011 Aug; 286(33):29388-29396. PubMed ID: 21700708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inducible nitric-oxide synthase and NO donor induce insulin receptor substrate-1 degradation in skeletal muscle cells.
    Sugita H; Fujimoto M; Yasukawa T; Shimizu N; Sugita M; Yasuhara S; Martyn JA; Kaneki M
    J Biol Chem; 2005 Apr; 280(14):14203-11. PubMed ID: 15805118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide inhibits the proliferation and invasion of pancreatic cancer cells through degradation of insulin receptor substrate-1 protein.
    Sugita H; Kaneki M; Furuhashi S; Hirota M; Takamori H; Baba H
    Mol Cancer Res; 2010 Aug; 8(8):1152-63. PubMed ID: 20663861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells.
    Kwon G; Corbett JA; Hauser S; Hill JR; Turk J; McDaniel ML
    Diabetes; 1998 Apr; 47(4):583-91. PubMed ID: 9568691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive activity of glycogen synthase kinase-3beta: positive regulation of steady-state levels of insulin receptor substrates-1 and -2 in adrenal chromaffin cells.
    Nemoto T; Yokoo H; Satoh S; Yanagita T; Sugano T; Yoshikawa N; Maruta T; Kobayashi H; Wada A
    Brain Res; 2006 Sep; 1110(1):1-12. PubMed ID: 16870161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFN-gamma synergizes with LPS to induce nitric oxide biosynthesis through glycogen synthase kinase-3-inhibited IL-10.
    Lin CF; Tsai CC; Huang WC; Wang CY; Tseng HC; Wang Y; Kai JI; Wang SW; Cheng YL
    J Cell Biochem; 2008 Oct; 105(3):746-55. PubMed ID: 18655171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. iNOS inhibitor, L-NIL, reverses burn-induced glycogen synthase kinase-3β activation in skeletal muscle of rats.
    Kaneki M; Fukushima Y; Shinozaki S; Fukaya M; Habiro M; Shimizu N; Chang K; Yasuhara S; Martyn JA
    Metabolism; 2013 Mar; 62(3):341-6. PubMed ID: 22995863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycogen synthase kinase 3 regulates IL-1β mediated iNOS expression in hepatocytes by down-regulating c-Jun.
    Lakshmanan J; Zhang B; Nweze IC; Du Y; Harbrecht BG
    J Cell Biochem; 2015 Jan; 116(1):133-41. PubMed ID: 25160751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-stranded RNA-dependent protein kinase is not required for double-stranded RNA-induced nitric oxide synthase expression or nuclear factor-kappaB activation by islets.
    Blair LA; Heitmeier MR; Scarim AL; Maggi LB; Corbett JA
    Diabetes; 2001 Feb; 50(2):283-90. PubMed ID: 11272138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose and fatty acids synergize to promote B-cell apoptosis through activation of glycogen synthase kinase 3β independent of JNK activation.
    Tanabe K; Liu Y; Hasan SD; Martinez SC; Cras-Méneur C; Welling CM; Bernal-Mizrachi E; Tanizawa Y; Rhodes CJ; Zmuda E; Hai T; Abumrad NA; Permutt MA
    PLoS One; 2011 Apr; 6(4):e18146. PubMed ID: 21541314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteasomal degradation of IRS-2, but not IRS-1 by calcineurin inhibition: attenuation of insulin-like growth factor-I-induced GSK-3beta and ERK pathways in adrenal chromaffin cells.
    Satoh S; Yanagita T; Maruta T; Nemoto T; Yoshikawa N; Kobayashi H; Tono T; Wada A
    Neuropharmacology; 2008 Jul; 55(1):71-9. PubMed ID: 18538359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide contributes to cytokine-induced apoptosis in pancreatic beta cells via potentiation of JNK activity and inhibition of Akt.
    Størling J; Binzer J; Andersson AK; Züllig RA; Tonnesen M; Lehmann R; Spinas GA; Sandler S; Billestrup N; Mandrup-Poulsen T
    Diabetologia; 2005 Oct; 48(10):2039-50. PubMed ID: 16132952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential phosphorylation of insulin receptor substrate-2 by glycogen synthase kinase-3 and c-Jun NH2-terminal kinase plays a role in hepatic insulin signaling.
    Sharfi H; Eldar-Finkelman H
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E307-15. PubMed ID: 18029441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRAF2 mediates JNK and STAT3 activation in response to IL-1β and IFNγ and facilitates apoptotic death of insulin-producing β-cells.
    Prause M; Berchtold LA; Urizar AI; Hyldgaard Trauelsen M; Billestrup N; Mandrup-Poulsen T; Størling J
    Mol Cell Endocrinol; 2016 Jan; 420():24-36. PubMed ID: 26610752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of adaptive and apoptotic unfolded protein response signalling by cytokine-induced nitric oxide production in mouse pancreatic beta cells.
    Chan JY; Cooney GJ; Biden TJ; Laybutt DR
    Diabetologia; 2011 Jul; 54(7):1766-76. PubMed ID: 21472432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducible nitric oxide synthase-nitric oxide plays an important role in acute and severe hypoxic injury to pancreatic beta cells.
    Ko SH; Ryu GR; Kim S; Ahn YB; Yoon KH; Kaneto H; Ha H; Kim YS; Song KH
    Transplantation; 2008 Feb; 85(3):323-30. PubMed ID: 18301327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role for c-Jun N-terminal kinase in beta-cell recovery from nitric oxide-mediated damage.
    Scarim AL; Nishimoto SY; Weber SM; Corbett JA
    Endocrinology; 2003 Aug; 144(8):3415-22. PubMed ID: 12865320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inducible nitric-oxide synthase is regulated by the proteasome degradation pathway.
    Musial A; Eissa NT
    J Biol Chem; 2001 Jun; 276(26):24268-73. PubMed ID: 11312270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-transcriptional regulation of human inducible nitric-oxide synthase expression by the Jun N-terminal kinase.
    Korhonen R; Linker K; Pautz A; Förstermann U; Moilanen E; Kleinert H
    Mol Pharmacol; 2007 May; 71(5):1427-34. PubMed ID: 17322004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycogen synthase kinase-3β indirectly facilitates interferon-γ-induced nuclear factor-κB activation and nitric oxide biosynthesis.
    Kai JI; Huang WC; Tsai CC; Chang WT; Chen CL; Lin CF
    J Cell Biochem; 2010 Dec; 111(6):1522-30. PubMed ID: 20872791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.